Ajanta Pharma Ltd. recalls Duloxetine Delayed-Release Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
- Products
-
- Duloxetine Delayed-Release Capsules
- Company
- Ajanta Pharma Ltd.
- Where it was sold
-
Nationwide within U.S
Nationwide
- Units affected
- 77,376 packs.
- About this recall
- Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-099-03